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Experimental Procedures: 
General  
Chemicals and reagents were purchased from commercial suppliers (Sigma-Aldrich, VWR, 
Chem-Impex International, Alfa Aesar) and used without further purification unless otherwise 
noted. Multitron shakers (Infors) were used for cell growth. UV-vis spectra were collected on a 
UV1800 Shimadzu spectrophotometer (Shimadzu). LC-MS data were collected on an Agilent 
1290 UHPLC with 6140 MS detector (Agilent Technologies). NMR data were collected on a 
Varian 300 MHz or 500 MHz spectrometer, or a Bruker 400 MHz spectrometer with a Prodigy 
broadband cryoprobe. High resolution mass data were collected with a JMS-600H (JEOL) 
instrument with the samples ionized by fast atom bombardment or by time-of-flight mass 
spectroscopy with an LCT Premier XE with UPLC (Waters). 
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Cloning, expression, and purification of PfTrpB 
The gene encoding PfTrpBWT (UNIPROT ID Q8U093) was previously codon-optimized for 
Escherichia coli and cloned into pET22(b)+ with a C-terminal his6-tag.1 Expression and 
purification protocols for the variants reported here were similar to those reported previously.1 
Briefly, a single colony of E.coli BL21 E. cloni Express cells (Lucigen) harboring the PfTrpB 
plasmid was used to inoculate a 5-mL culture of Terrific Broth with 100 µg/mL ampicillin 
(TBamp) and incubated overnight at 37 C and 250 rpm. This culture was used to inoculate a 500-
mL TBamp expression culture, which was incubated at 250 rpm and 37 C for ~ 3 h or until an 
OD600 of 0.8 was reached. Cultures were chilled on ice for 20 min and expression was induced 
by the addition of 500 mM isopropyl -D-thiogalactopyranoside (IPTG) to a final concentration 
of 1 mM. Cells continued to grow shaking at 250 rpm and 20 C for another 20 h. Cells were 
harvested by centrifugation at 4 C and 5,000g for 10 min; the pellets were frozen at -20 C until 
further use.  
For preparation as a heat treated lysate, frozen cell pellets were thawed at room temperature and 
resuspended in 50 mM potassium phosphate buffer, pH 8.0, with 200 µM PLP, 1 mg/mL hen egg 
white lysozyme, and 0.02 mg/mL DNAse. After vortexing, cells were lysed with BugBuster 
(Novagen) according to the manufacturer’s recommendations, and the cleared lysates were 
centrifuged at 20,000g and 4 C for 10 min. The lysates were then incubated at 75 C for 10 min, 
centrifuged again as described above and buffer exchanged into 50 mM potassium phosphate 
buffer pH 8.0, snap-frozen in liquid N2 and stored at -80 C until further use.  
For purification, frozen cell pellets where thawed and treated as above with modification of the 
lysis buffer: 50 mM phosphate buffer, pH 8.0, with 20 mM imidazole and 100 mM NaCl (buffer 
A), with 200 µM PLP. The heat-treated lysate was applied to a 1-mL Histrap HP column (GE 
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Healthcare). The purification was performed with an AKTA purifier FPLC system (GE 
Healthcare). PfTrpB eluted during a linear gradient from buffer A to buffer B (50 mM phosphate 
buffer with 500 mM imidazole and 100 mM NaCl, pH 8.0) at 140 mM imidazole. Purified 
PfTrpB was desalted into 50 mM phosphate buffer, pH 8, frozen in liquid N2, and stored at -80 
C until further use.  
Purified protein concentrations were determined via the Bradford assay (Bio-Rad). The 
concentration of PfTrpB2B9 in heat-treated lysates was determined by specific activity. 
Tryptophan formation was monitored at 75 C over 1 min at 290 nm using Δε290 = 1.89 mM-1 
cm-1.2 The assay buffer contained 200 mM potassium phosphate pH 8.0, and 5 µM PLP. Using 
purified PfTrpB2B9, we recorded an activity of 0.9 s-1 with 400 µM indole and 20 mM Ser. Using 
this parameter, we calculated that 375 mg of PfTrpB2B9 active catalyst was obtained per liter of 
culture as a heat-treated lysate.  
 
Library construction 
The error-prone PCR library was constructed with 200, 300 and 400 µM MnCl2 as the mutagen 
using the gene for PfTrpB4D11 as the parent. The recombination library of hits found in the 
random mutagenesis studies (I16V, Q89L, F95L, L182P, Y192H, and V384A) was constructed 
using site-directed mutagenesis by overlap extension (SOE) PCR.3 The library was constructed 
from fragments that were DpnI digested, gel purified, and used as template for the subsequent 
assembly PCR using the flanking primers only. The process is described in greater detail in 
Buller et al.1 Each library was cloned into pET22(b)+ between restriction sites NdeI and XhoI in 
frame with the C-terminal his-tag for expression in E. coli BL21 E. cloni Express cells. 
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High-throughput screening 
For high-throughput expression, BL21 E. cloni Express cells carrying PfTrpB4D11 and variant 
plasmids were grown in 96-well deep well plates in 300 L TBamp at 37 C and 80 % humidity 
with shaking at 250 rpm overnight. TBamp expression cultures (630 L) were inoculated with 20 
L of the overnight cultures and continued to grow at 37 C and 80 % humidity with shaking at 
250 rpm for 3 h. Expression was induced with the addition of ITPG to a final concentration of 1 
mM to pre-chilled (20 min on ice-water bath) cultures. The expression continued for another 20 
h at 20 C with shaking at 250 rpm. Cells were then centrifuged at 4000g for 10 min and frozen 
at – 20 C overnight. For screening, cells were allowed to thaw at room temperature and then 
lysed in buffer consisting of 200 mM phosphate buffer, pH 8.0, with 1 mg/mL lysozyme and 
~0.05 mg/mL DNaseI. To increase the enzyme concentration, 350 L/ well was used for the 
error-prone PCR library and 400 L/ well was used for the recombination library. Cells were 
lysed via incubation at 37 C for 1 h. After centrifugation at 5,000g for 20 min, 180-L aliquots 
of the lysates (160-L aliquot for recombination libraries) were transferred into PCR plates 
(USA Scientific, Ocala, USA), heat-treated for 1 h at 75 C, and then spun again at 1,000g and 4 
C for 30 min. After the addition of 120-L assay buffer (50 mM phosphate buffer, 41.6 mM L-
threonine, 0.833 mM indole, pH 8.0) to 80 L of cleared, heat-treated lysates in UV-transparent 
assay plates (Evergreen Scientific), the plates were sealed and incubated at 75 C for up to 45 
min (generation 1: 30 min, generation 2: 45 min). The reactions were then arrested by incubation 
in an ice-water bath, and the amount of β-MeTrp formed was recorded at 290 nm with a plate 
reader (Tecan Infinite M200).  
Low enzyme activity in the first generation led to a relatively high error in the assay (CV ~50 %) 
and only the nine hits with activity 2.5-fold greater than parent were selected for subsequent 
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sequencing and rescreening (Figure S2). One of the hits was revealed to be the parent sequence, 
and three contained only silent mutations. Cultures of each hit containing missense mutations 
were grown in triplicate on 5-mL scale, and expression and lysis proceeded in the same manner 
as described in the Cloning, Expression and Purification section above. Reactions using 10 µM 
of protein as heat-treated lysate (determined by Bradford assay) and 20 mM of indole and Thr 
were run for 1 h at 75 °C and quenched by dilution to 50% acetonitrile (ACN). Samples were 
analyzed by quantitation of product on HPLC, and the increase in activity relative to parent is 
shown in Table S3.  
For the second generation, each of the silent mutations identified through error-prone were added 
to the PfTrpB4D11 plasmid and the resultant construct was found to have higher expression under 
the growth conditions of the high-throughput screen, but not when grown at larger scale in a 
shaking flask. Nonetheless, this construct was used as the parent for the recombination libraries 
(described above), which were screened under similar conditions as the random mutagenesis 
libraries. Many potentially activated proteins were identified from the recombination library but 
rescreening the top five hits showed that only a single protein, PfTrpB2B9 had activity that was 
greater than the most active variant from the random mutagenesis library (Table S4). 
 
UV-Vis spectroscopy 
Spectra were collected between 550 and 250 nm on a UV1800 Shimadzu spectrophotometer 
(Shimadzu) using 20 µM of enzyme in 200 mM potassium phosphate pH 8.0 in a quartz cuvette. 
Samples were incubated at 75 °C for > 3 min to ensure a stable temperature was reached. Stage I 
of the reaction was initiated by addition of 20 mM L-threonine, and the spectra were measured in 
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< 15 s to limit production of α-ketobutyrate from deamination of L-threonine, which absorbs at 
320 nm. 
 
Specificity Measurement 
We measured the selectivity of PfTrpB2B9 for L-serine vs. L-threonine by direct competition. A 
200 µL reaction containing 1 µM enzyme, 5 mM indole, 10 mM L-serine, 10 mM L-threonine in 
0.2 M potassium phosphate buffer pH 8.0 was allowed to proceed overnight in a water bath at 75 
°C. Reactions were quenched with 200 µL ACN and analyzed via LC-MS, which showed only 
the canonical L-tryptophan product within the limits of detection, suggesting > 1000-fold 
specificity for L-serine.  
 
Total Turnover Number (TTN) determination 
Measurements were made using HPLC and LC-MS instruments. The amount of Trp formed was 
measured at 280 nm using a standard curve with trichlorobenzene as internal standard. 
Measurement of the UV-absorption spectrum of β-MeTrp showed an identical spectrum (Figure 
S9), and the same curve was employed for both products while determining the TTN for the 
catalysts engineered for activity with Ser. Later, it was found that the conversion could be 
measured by monitoring at 277 nm, the isosbestic point for the conversion of indole to L-Trp or 
β-MeTrp, and calculating the ratio of product peak to the sum of the substrate and product peaks. 
This method is insensitive to loading volume, and results agreed with measurements using a 
standard curve. This method of TTN determination is only accurate when there are no competing 
reactions with indole or product, which we observed for the conditions employed here. We used 
this technique to determine the TTN of the PfTrpB2B9 reaction with different nucleophiles. The 
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isosbestic point for the conversion of substrate to product was measured using a time course UV-
vis analysis of the reaction catalyzed by PfTrpB2B9 using L-Ser as the amino acid source because 
the reactions are significantly faster than with L-Thr and the β-Me group does not change the 
absorbance spectrum of the product (Table S5). Next, reactions were set up in triplicate using a 
total volume of 150 µL with 25 mM nucleophile and 250 mM L-Thr in 200 mM potassium 
phosphate pH 8.0 in borosilicate glass vials, as plastics can absorb indoles at high temperatures. 
Before addition of enzyme, all reagents were transferred into a Coy anaerobic chamber with < 1 
ppm O2 to rapidly exchange the atmosphere in the headspace of the vials to 98/2% N2/H2, which 
limits competing non-catalytic oxidation of indoles. Enzyme was added in the anaerobic 
environment with varied catalyst loading to ensure a robust product signal in subsequent 
analysis. Reaction vessels were capped before being removed from the anaerobic chamber and 
incubated in a 75 °C water bath for 24 h. Reactions were quenched the next day by addition of 1 
volume (150 µL) of 100% ACN, mixing, and allowing to rest at room temperature for 10 min. 
Quenched solutions were then diluted 5-fold with 40% ACN in water and analyzed via LC-MS. 
In all cases, auxiliary peaks that would indicate non-catalytic degradation of substrate were 
present at only low levels, contributing to < 1% of the total integration signal for a given 
wavelength.  For 7-azaindole, a second peak with m/z = 220 was observed that was also found in 
larger scale reactions and whose properties are consistent with an N-alkylated product.  
Different conditions were needed to ascertain the TTN with thiophenol because of competing 
oxidation by molecular oxygen. Use of sparged buffers and addition of dithiothreitol (DTT) 
helped to limit oxidation. A 5-mL reaction containing 25 mM thiophenol, 250 mM Thr, 12.5 mM 
DTT, and 0.02 mol % catalyst loading was prepared in the Coy anaerobic chamber. The reaction 
was allowed to proceed for 55 hours, during which the solution slowly became cloudy as the 
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thiophenol oxidized. The reaction was analyzed via LC-MS and integration of the product peak 
at 254 nm after 55 hrs was compared to the total integration at 20 hrs, before significant 
oxidation had occurred. This ratio indicated 24 % conversion for 1,200 turnovers.  
 
Protein Crystallography 
PfTrpBWT crystallization conditions were identified previously,1 and crystals routinely grew in 
sitting drops against a 1-mL reservoir of 15-25% PEG3350 and 0.1 M Na HEPES pH 7.85 with 
mother liquor comprised of 1.5 µL of 8.0 mg/mL PfTrpBWT and 1.5 µL of well solution. Ligand-
bound structures were determined by soaking crystals of PfTrpBWT with 100 mM L-threonine for 
2 min. Crystals were cryo-protected through oil immersion in Fomblin Y (Sigma) and flash 
frozen in liquid N2 until diffraction. Diffraction data were collected remotely at the Stanford 
Synchrotron Radiation Laboratories on beamline 12-2. Crystals routinely diffracted at or below 
2.0 Å, and the data were integrated and scaled using XDS 4 and AIMLESS. 5 A resolution cutoff 
of CC1/2 > 0.3 was applied along the strongest axis of diffraction.5, 6 These data contributed to 
model quality as judged by Rfree in the final bin < 0.4. The structure was solved using molecular 
replacement with PHASER, as implemented in CCP4.7, 8 The search model comprised a single 
monomer of PfTrpBWT (PDB ID: 5DW3) subjected to 10 cycles of geometric idealization in 
Refmac5 and removal of all ligands. Model building was performed in Coot 9 beginning with 
data processed at 2.4 Å, followed by subsequent inclusion of increasingly higher resolution 
shells of data with relaxed geometric constraints. Refinement was performed using REFMAC5.10 
The MolProbity server was used to identify rotamer flips and clashes.11 After the protein, ligand, 
and solvent atoms were built, TLS operators were added to refinement, which resulted in 
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substantial improvements in Rfree for the models. Crystallographic and refinement statistics are 
reported in Table S2. The structure is deposited with PDB ID: 5IXJ. 
 
Identification of β-methyl amino acid products 
The identities of the amino acid products were confirmed by 1H, 13C, and 19F NMR and high-
resolution mass spectrometry (HRMS). Proton NMR spectra were recorded on a Varian 300 or 
500 MHz or Brucker 400 MHz spectrometer. Proton chemical shifts are reported in ppm (δ) 
relative to tetramethylsilane and calibrated using the residual solvent resonance (CD3OD, δ 3.31 
ppm; D2O, δ 4.79 ppm). Data are reported as follows: chemical shift (multiplicity [singlet (s), 
doublet (d), doublet of doublets (dd), doublet of doublets of doublets (ddd), triplet (t), triplet of 
doublets (td)], coupling constants [Hz], integration). Carbon NMR spectra were recorded on a 
Varian 300 or 500 MHz or Brucker 400 MHz spectrometer with proton decoupling. Carbon 
chemical shifts are reported in ppm (δ) relative to tetramethylsilane and calibrated using the 
residual solvent resonance (CD3OD, δ 49.00). Fluorine NMR spectra were recorded on a 300 
MHz (282 MHz) spectrometer without proton decoupling. Fluorine chemical shifts are reported 
in ppm relative to FCCl3 (δ 0.00 ppm) and were calibrated automatically by the spectrometer 
using the solvent deuterium lock signal. High-resolution mass spectra were obtained on a JMS-
600H HRMS (JEOL) using fast atom bombardment. 
Reaction with heat-treated lysate: Reactions were conducted using PfTrpB2B9, which was 
prepared by heat-treatment as described above. The protein was used as a solution in potassium 
phosphate buffer (50 mM, pH 8.0) and the concentration varied between preps between 97 µM 
and 670 µM, as determined by specific activity. Threonine was added as a solid and PLP was 
used as a 15 mM aqueous solution. 
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Generally, reactions were conducted in 2–5 mL volume with the following reagents added 
sequentially: 0.1 M nucleophile, 1.0 M threonine, 0.2 M potassium phosphate buffer pH 8.0 with 
dimethyl sulfoxide (5% of final volume), and a 5-fold molar excess of PLP relative to enzyme. 
Finally, the enzyme solution was added and the vial was capped and immersed in a water bath 
that had been equilibrated to 75 °C.  After 16–24 h, the reaction mixture was allowed to cool to 
room temperature, then purified directly on C18 silica (20-mL column volume) using an Isolera 
automated column instrument (Biotage) with 0% to 100% ACN/H2O or  0% to 100% 
MeOH/H2O. The method holds for 5-7 column volumes at 1% ACN (or MeOH) to wash the 
majority of the DMSO from the column before initializing the gradient, which runs over 10 
column volumes. From this procedure the vast majority of DMSO is removed, however a trace 
amount remains. Product can be re-columned with the above procedure to remove this residual 
solvent.  
Analysis of diastereoselectivity: Diastereoselectivity of each product is assessed at the 
conclusion of the reaction via LC-MS analysis and later during isolation. In all but two instances, 
a single peak with the predicted mass is observed. The reaction with 7-azaindole yielded two 
peaks,. however isolation of this second compound and analysis by 1H-NMR revealed a clear 
quartet of doublets at 5.2 ppm not consistent with a second diastereomer, but rather an N-
alkylated regioisomer (spectra are provided below). A similar second peak was inconsistently 
observed with reactions using 4-fluoroindole. While we cannot unequivocally rule out that this is 
a second diastereomer, the above observations suggest this is also a trace N-alkylation product. 
Analysis of enantioselectivity: The TrpS enzyme system has been extensively studied and does 
not produce D-Trp at a measurable level, consistent with its biological function. The 
configuration of the (2S,3S)-β-methyl-tryptophan product, which was a known compound,12 was 
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assigned based on the 1H-NMR chemical shift of the β-methyl group, for which there is a clear 
difference between the (2S,3R) compound. This retention of configuration matches the known 
stereochemical outcome of the TrpS reaction performed using H,D-labelled L-serine.13 The 
configuration of the β-Me-Trp analogs is inferred by analogy to the parent compound. To further 
assess the stereochemical purity of the products, we derivatized the amino acid products with 
both racemic and enantiopure N-(5-fluoro-2,4-dinitrophenyl)alanamide (FDNP-alanamide) for 
comparison.14 Approximately 1.0 µmol of amino acid product was resuspended in 10 µL of 1.0 
N aqueous HCl and aliquoted into 2 glass HPLC vials containing 97 µL of 1 M aqueous 
NaHCO3. Two equivalents of FDNP-alanamide were added to each vial as a 33 mM solution in 
acetone. In one reaction the reagent added is enantiopure and in the other a racemate is added. 
This solution was incubated at 37 °C for 1 h, diluted by the addition of 500 µL 50 % ACN/H2O 
and analyzed by LC-MS, which indicated >99 % ee for each compound tested.  
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Supplemental Tables 
Table S1. Total turnovers catalyzed by TrpB enzymes prior to evolution for activity with L-
threonine. 
 
 
 
 
 
Activity measured using 1 µM of purified enzyme in 0.2 M potassium phosphate buffer pH 8.0 
with 20 mM of each reactant, L-threonine and indole, with a 24-h reaction at 75 °C.  
 
Table S2. Crystallographic data collection and refinement statistics 
Protein    PfTrpBWT 
Ligand    L-Threonine 
Data Collection 
Space group    P212121 
Cell dimensions (Å)    a,b,c =  86.2, 112.4, 160.3 
Cell angles    α = β = γ = 90° 
Wavelength (Å)    0.9795 
Beamline    SSRL 12.2 
Resolution (Å)    40 – 1.54 
Last bin (Å)    (1.57 – 1.54) 
No. observations    2,230,262 
Completeness (%)    98.9 (78.1) 
Rpim (%)    0.021 (0.577) 
CC(1/2)    1.000 (0.587) 
I/σI    19.4 (1.3) 
Redundancy    9.8 (5.5) 
Refinement 
Total no. of reflections    214,599 
Total no. of atoms    12,924 
Final bin (Å)    (1.54 – 1.58) 
Rwork (%)    17.5 (30.7) 
Rfree (%)    19.5 (31.7) 
Average B factor (Å2)    25.1 
Ramachandran plot Favored, 
% 
   97.9 
Allowed, %    99.8 
Outliers, %    0.2 
Values in parenthesis are for the highest resolution shell 
Rmerge is Σ|Io – I| / ΣIo, where Io is the intensity of an individual reflection, and I is the mean 
intensity for multiply recorded reflections 
Rwork is Σ||Fo – Fc|| / Fo, where Fo is an observed amplitude and Fc a calculated amplitude;  
Rfree is the same statistic calculated with a 5% subset of the data that was included in refinement. 
Ramachandran statistics calculated by the MolProbity server. 
Entry Enzyme Turnovers 
1 PfTrpBWT 66 
2 PfTrpBT292S 420 
3 PfTrpB4D11 660 
4 PfTrpB0B2 180 
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Table S3. Activity of hits from random mutagenesis library relative to parent 
 
Variant Fold 
Improvement 
Mutations 
PfTrpB4D11 1.0 (parent)  
PfTrpB3C7 1.5 I16V, Q89L 
PfTrpB4H5 0.9 L182P 
PfTrpB4G1 2.4 F95L 
PfTrpB4E9 1.2 V384A 
PfTrpB2A9 1.3 Y192H 
Improvement measured as increase in β-MeTrp formation using heat-treated lysate after 60-min 
reaction at 75 °C. Concentration of the protein was normalized for all variants. See SI 
Experimental Procedures for details. 
 
Table S4. Activity of hits from recombination library relative to parent 
Variant Fold Improvement Mutations 
PfTrpB4G1 1.0 (parent) F95L 
PfTrpB1B5 0.3 I16V, F95L, L182P, V384A 
PfTrpB1F4 0.8 I16V, F95L, Y192H, V384A 
PfTrpB3H2 < 0.01 I16V, A93V, F95L, Y192H, V384A  
PfTrpB1E4 < 0.01 I16V, Q89L, F95L, L182P, V384A  
PfTrpB2B9 1.7 I16V, F95L, V384A  
Improvement measured as increase in β-MeTrp formation after 90-min reaction at 75 °C without 
normalization for protein expression. See SI Experimental Procedures for details. 
 
Table S5. TTN of β-substitution reactions with L-Thr and different indole nucleophiles 
Nucleophile 
Isosbestic Point 
(nm) 
Catalyst Loading 
(%) 
TTN 
Indole 277 0.01 8200 ± 1600 
2-Methylindole 279 0.01 6400 ± 1400 
6-Methylindole 273 0.01 1100 ± 100 
4-Fluoroindole 267 0.1 380 ± 10 
5-Fluoroindole 282 0.01 1300 ± 280 
Indazole 276 0.04 500 ± 40 
7-Azaindole 292 0.1 
C-alkylation - 220 ± 40 
N-alkylation - 32 ± 3 
Activity measured via LC-MS and conversion as the ratio of substrate to total peak intensity at 
the isosbestic point after 24-h reaction at 75 °C. See SI Experimental Procedures for details. 
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Supplemental Figures 
 
Figure S1. Different amines tested for reactivity with PfTrpB0B2. Product formation was 
assessed by LC-MS analysis. Boxes indicate substrates for which the expected product mass was 
observed. 
 
 
Figure S2. Retention of function curves for PfTrpB4D11 random mutagenesis library for activity 
with Thr and indole. Legend refers to the concentration of MgCl2 (in µM) used to introduce 
mutations; two plates with 300 µM MnCl2 were assayed. The variance in the assay is attributed 
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to the relatively low activity of the parent enzyme, whose activity is close to the limit of 
detection in the assay used here. 
 
Figure S3. Modeling the Thr external aldimine of PfTrpB based on the 2.0-Å X-ray crystal 
structure of the Ser external aldimine with PfTrpB (PDB ID: 5DW0). Spheres shown represent 
the group van der Waals radii and their intersection indicates a steric clash between the Thr β-
methyl group and the backbone of Gly298, black dashes. Yellow dashes indicate a hydrogen 
bond between Thr and the sidechain of Asp300.  
 
Figure S4. UV-vis analysis of the reaction between Thr and engineered TrpB proteins. The black 
trace shows the internal aldimine resting state of each catalyst and the traces in increasingly dark 
E(Ain) 
20 mM Thr 
PfTrpBT292S  
PfTrpB4D11 
PfTrpB4G1 
PfTrpB2B9 
PfTrpB2B9 
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shades of blue are engineered proteins with the addition of 20 mM Thr. The increase in 
absorbance at 350 nm and broad shoulder extending past 500 nm are consistent with steady-state 
accumulation of an E(A-A) intermediate. The slight shift to the right of the peak at 412 nm 
suggests a mixed population of E(Ain) and E(Aex1) is also present in solution. Spectra were 
collected at 75 °C using 20 µM purified protein. 
                
Figure S5. Comparison of steady state intermediates of PfTrpB2B9 in a reaction with either Thr 
or Ser. In its resting state, the PLP of PfTrpB2B9 exists as the E(Ain) (black). When 20 mM Ser is 
added as the amino acid source the prominent λmax at 350 nm with a broad shoulder to 550 nm is 
indicative of E(A-A) formation (red). The residual peak at ~420 nm indicates some E(Aex1) is 
also present in solution. Addition of 20 mM Thr also shows a λmax at 350 nm, however it is less 
prominent than the E(Aex1) peak (blue). Spectra were collected at 75 °C using 20 µM purified 
protein. 
 
PfTrpB2B9  
PfTrpB2B9 + 20 mM Thr 
PfTrpB2B9 + 20 mM Ser 
 
 
E(A-A) 
E(Ain) 
E(Aex1) 
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Figure S6. Any KD gradient SDS-PAGE gel of PfTrpB2B9. Lane 1 = Protein Ladder (Bio-Rad). 
Lane 2 = Whole cells expressing PfTrpB2B9. Lane 3 = Soluble fraction upon lysis. Lane 4 = Heat 
treated lysate. Lane 5 = Purified via His-trap.  
 
Figure S7. Effect of Thr:indole stoichiometry on β-substitution reaction. Reactions conducted 
using 25 mM indole in 0.2 M potassium phosphate pH 8.0 with 0.02 mol% PfTrpB2B9 catalyst. 
The maximum of 5,000 TTN was achieved with five equivalents of Thr. Additional Thr was not 
deleterious to the reaction. 
25  
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Figure S8. UV-vis analysis of PfTrpB2B9 Thr deamination activity. Black trace shows the 
enzyme E(Ain) spectrum before addition of substrate. Upon addition of 20 mM Thr, the 
spectrum shifts to reflect the steady-state distribution of stage I intermediates of the catalytic 
cycle. The features of the spectrum past 390 nm remain constant while there is a linear increase 
in broad absorbance at 320 nm that is consistent with deamination of Thr to form α-ketobutyrate 
and ammonium. The initial spectrum upon addition of Thr was collected within 5 s and each 
subsequent trace is separated by 1 min. Reaction conducted with 20 µM PfTrpB2B9.  
 
Figure S9. Absorbance spectra of indole (red), Trp (blue), and β-MeTrp (green). Each sample 
was prepared as 100 µM solution in H2O. 
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β-Alkyl Amino Acid Synthesis 
 
(2S,3S)-2-amino-3-(1H-indol-3-yl)butanoic acid (5). A 20 mL vial was charged with indole 
(59.3 mg) and L-Thr (595.6 mg). The substrates were suspended in 3.97 mL of aq. potassium 
phosphate (0.2 M, pH 8.0) with 250 µL DMSO (5% final volume). Aq. PLP was added from a 
15 mM stock in H2O to achieve a final concentration of 100 µM. Lastly, 625 µL of PfTrpB
2B9 
(160 µM) was added as a heat-treated lysate for a final reaction volume of 5.0 mL with 0.02 mol 
% catalyst loading with respect to indole. The reaction was allowed to proceed overnight at 75 
°C in an oil bath. (A slight orange color developed overnight, consistent with non-catalytic 
oxidation of indole.) After 16.7 hours, approximately 90 % of indole was converted to product, 
as indicated by the UV absorbance at 280 nm from LC-MS analysis of the reaction mixture. The 
product was purified by flash chromatography using C18-silica, which was first prepared as a gel 
with MeOH and then equilibrated to 100 % H2O. The reaction mixture was applied to the 
column and washed with 2 column volumes (CVs) of 100 % H2O. The product was subsequently 
eluted with 2 CVs of 50% MeOH/H2O. Fractions were assessed for the presence of product using 
LC-MS, and those that contained it were pooled and concentrated with a rotary evaporator. The 
product was dissolved in H2O, frozen on dry ice, and lyophilized overnight. From this procedure 
85.0 mg of a pale brown solid product were obtained that, correcting for trace DMSO that was 
carried over during the purification, indicate an isolated yield of 75 %. This trace DMSO was 
removed by further purification using automated flash chromatography using a C18-silica 
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column with a gradient from 0 to 100% methanol and subsequent lyophilization of the pooled 
product fractions. Marfey’s analysis of the product indicated the reaction proceeded with > 99 % 
ee.  
1H NMR (300 MHz, Methanol-d4) δ 7.72 (dt, J = 8.0, 1.0 Hz, 1H), 7.35 (dt, J = 8.2, 1.0 Hz, 1H), 
7.18 (s, 1H), 7.10 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.01 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H), 3.72 (d, J = 
7.6 Hz, 1H), 3.52 (p, J = 7.3 Hz, 1H), 1.53 (d, J = 7.2 Hz, 3H). 13C NMR (101 MHz, Methanol-
d4) δ 175.37, 138.78, 127.80, 124.27, 122.86, 120.38, 120.13, 115.66, 112.67, 61.94, 35.71, 
19.85. MS (FAB) (m/z) for [M+H]+ C12H15N2O2 requires 219.1134, observed 219.1120.  
 
 
(2S,3S)-2-amino-3-(2-methyl-1H-indol-3-yl)butanoic acid. A 5 mL vial was charged with 2-
methylindole (27.3 mg) and L-Thr (238.2 mg). The substrates were suspended in 1.78 mL 0.2 M 
potassium phosphate pH 8.0 with 100 µL DMSO (5 % final) and PLP was added from a 15 mM 
stock in H2O to a final concentration of 130 µM. Lastly, 111 µL of 240 µM PfTrpB
2B9 was added 
as a heat-treated lysate for a final reaction volume of 2.0 mL with 0.013 mol % catalyst loading 
with respect to 2-methyl-indole. The reaction was allowed to proceed overnight in an water bath 
at 75 °C. Approximately 93 % of 2-methyl-indole was converted to product, as indicated by the 
UV absorbance at 279 nm from LC-MS analysis of the reaction mixture, however this may be an 
overestimate, as the substrate was sampled as a suspension. The product was purified using 
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automated flash chromatography using a C18-silica column with a gradient from 0 to 100% 
methanol. The fractions containing product, as indicated by LC-MS, were pooled and 
concentrated by rotary evaporation. From this procedure 35 mg of a pale yellow solid product 
were obtained that, correcting for trace DMSO that was carried over during the purification, 
indicate an isolated yield of 72 %. Marfey’s analysis of the product indicated the reaction 
proceeded with > 99 % ee. 
1H NMR (400 MHz, Deuterium Oxide) δ 7.68 (dt, J = 7.7, 1.0 Hz, 1H), 7.42 (dt, J = 8.1, 1.0 Hz, 
1H), 7.17 (ddd, J = 8.1, 7.1, 1.3 Hz, 1H), 7.11 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 3.97 (d, J = 10.0 
Hz, 1H), 3.34 (dq, J = 10.0, 7.2 Hz, 1H), 2.39 (s, 3H), 1.50 (d, J = 7.2 Hz, 3H). 13C NMR (101 
MHz, Deuterium Oxide) δ 175.07, 135.60, 134.63, 125.76, 121.05, 119.15, 118.39, 111.28, 
108.27, 59.88, 33.46, 17.09, 10.77. MS (FAB) (m/z) for [M+H]+ C13H17N2O2 requires 233.1290, 
observed 233.1286. 
 
 
(2S,3S)-2-amino-3-(6-methyl-1H-indol-3-yl)butanoic acid. A 20 mL vial was charged with 6-
methylindole (21.7 mg) and L-Thr (71.0 mg). The substrates were suspended in 1.27 mL aq. 
potassium phosphate (0.2 M, pH 8.0) with 82.5 µL DMSO (5% of final volume), then aq. PLP 
was added from a 15 mM stock solution to achieve a final concentration of 100 µM. Lastly, 199 
µL of 671 µM PfTrpB2B9 was added as a heat-treated lysate for a final reaction volume of 1.65 
mL with 0.1 mol % catalyst loading with respect to 6-methyl-indole. The reaction was allowed to 
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proceed in a water bath at 75 °C.  After 1 h, 46 mg additional Thr was added. Because the 6-
methyl-indole was not fully dissolved in solution an additional 350 µL of buffer were added to 
decrease the concentration. After 2 h, 80 mg of Thr were added for a final amount of 196.5 mg 
Thr (10 eq). The reaction was allowed to proceed overnight at 75 °C. Approximately 92 % of 6-
methyl-indole was converted to product, as indicated by the UV absorbance at 274 nm from LC-
MS analysis of the reaction mixture, however this may be an overestimate, as the substrate was 
sampled as a suspension. The product was purified using automated flash chromatography using 
a C18-silica column with a gradient from 0 to 100% acetonitrile. The fractions containing 
product, as indicated by LC-MS, were pooled and concentrated by rotary evaporation. The light 
yellow solid was dissolved in 2 mL H2O, frozen on dry ice, and lyophilized overnight. This 
procedure afforded 20.1 mg of product for an isolated yield of 52%. Marfey’s analysis of the 
product indicated the reaction proceeded with > 99 % ee. 
1H NMR (400 MHz, Methanol-d4) δ 7.39 (d, J = 8.1 Hz, 1H), 6.96 (s, 1H), 6.91 (s, 1H), 6.67 
(dd, J = 8.2, 1.4 Hz, 1H), 3.55 (d, J = 7.5 Hz, 1H), 3.12 (p, J = 1.6 Hz, 1H), 1.33 (d, J = 7.2 Hz, 
3H). 13C NMR (101 MHz, Methanol-d4) δ 174.4, 139.1, 132.4, 125.4, 123.6, 121.8, 119.9, 
114.9, 112.4, 61.4, 35.1, 21.8, 19.6. MS (FAB) (m/z) for [M+H]+ C13H17N2O2 requires 233.1290, 
observed 233.1289. 
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(2S,3S)-2-amino-3-(4-fluoro-1H-indol-3-yl)butanoic acid. A 6 mL vial was charged with 4-
fluoroindole (28.6 mg) and L-Thr  (75.6 mg). The substrates were suspended in 0.58 mL of aq. 
potassium phosphate (0.2 M, pH 8.0) with 100 µL DMSO (5% of final volume), then aq. PLP 
was added from a 15 mM stock solution to achieve a final concentration of 100 µM. The mixture 
was then sparged with Ar(g) to remove O2. Lastly, 1250 µL of 160 µM PfTrpB
2B9 was added as a 
heat-treated lysate for a final reaction volume of 2.0 mL with 0.1 mol % catalyst loading with 
respect to 4-fluoro-indole. The reaction was allowed to proceed in an oil bath at 75 °C. After 1 h, 
79.8 mg additional Thr was added. After 2 h, 82.8 mg of Thr were added for a final amount of 
238.2 mg Thr (10 eq). The reaction was allowed to proceed overnight at 75 °C and monitored the 
following day by LC-MS analysis. The product peak continued to increase until 1585 min after 
initiation, however it was not allowed to proceed for a second night. Approximately 47 % of 4-
fluoro-indole was converted to product, as indicated by the UV absorbance at 280 nm, however 
this wavelength overestimates the product formed. The product was purified using the same 
protocol as described for β-methyltryptophan. In the late-eluting fractions from the column, a 
minor peak with m/z = 237 was observed, suggestive of N-alkylation, however this compound 
could not be isolated in sufficient quantity for characterization. From this procedure 9.4 mg of 
purified product were obtained, indicating 19 % isolated yield. We were unable to complete 
Marfey’s analysis for this product. However, as described above, the appearance of a single peak 
in the LC-MS indicating >99 % dr. Coupled with the fact that the engineered PfTrpB catalysts 
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are highly enantioselective with 4-F-indole and Ser,1 there is strong support for assigning the 
stereochemistry of this product.  
1H NMR (500 MHz, Methanol-d4) δ 7.20 (s, 1H), 7.18 (d, J = 8.2 Hz, 1H), 7.05 (td, J = 8.0, 5.0 
Hz, 1H), 6.71 (dd, J = 11.7, 7.7 Hz, 1H), 3.81 (d, J = 9.0 Hz, 1H), 3.46 (p, J = 7.2 Hz, 1H), 1.49 
(d, J = 6.9 Hz, 3H). 19F NMR (282 MHz, Methanol-d4) δ -120.84 (d, J = 11.7 Hz).
 
13C NMR 
(126 MHz, Methanol-d4) δ 175.1, 158.2 (d, J = 243.1 Hz), 142.0 (d, J = 12.2 Hz), 126.1–122.2 
(m), 116.1 (d, J = 20.3 Hz), 115.3 (d, J = 3.6 Hz), 109.3 (d, J = 3.4 Hz), 105.3 (d, J = 20.7 Hz), 
62.2, 36.6, 19.9 (d, J = 3.4 Hz). MS (FAB) (m/z) for [M+H]+ C12H14FN2O2 requires 237.1039, 
observed 237.1032. 
 
(2S,3S)-2-amino-3-(5-fluoro-1H-indol-3-yl)butanoic acid. A 6 mL vial was charged with 5-
fluoroindole (27.1 mg) and L-Thr  (63.6 mg). The substrates were suspended in 1.24 mL of aq. 
potassium phosphate (0.2 M, pH 8.0) with 100 µL DMSO (5% of final volume), then aq. PLP 
was added from a 15 mM stock solution to a achieve a final concentration of 100 µM. The 
mixture was then sparged with Ar(g) to remove O2. Lastly, 1250 µL of 160 µM PfTrpB
2B9 was 
added as a heat-treated lysate for a final reaction volume of 2.0 mL with 0.1 mol % catalyst 
loading with respect to 5-fluoro-indole. The reaction was allowed to proceed in an oil bath at 75 
°C. After 1 h, 63.6 mg additional Thr was added. After 2 h, 58.0 mg of Thr were added. After 4 
h, 59.0 mg of Thr were added for a final amount of 244.2 mg Thr (10 eq). The reaction was 
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allowed to proceed overnight at 75 °C and monitored the following day by LC-MS analysis. 
Approximately 77 % of 5-fluoro-indole was converted to product, as indicated by the UV 
absorbance at 280 nm. The product was purified using the same protocol as described for β-
methyl-tryptophan. From this procedure 31.1 mg of a white solid were obtained, indicating 64 % 
isolated yield. Marfey’s analysis of the product indicated the reaction proceeded with > 99 % ee. 
1H NMR (300 MHz, Methanol-d4) δ 7.41 (ddd, J = 10.2, 2.5, 0.6 Hz, 1H), 7.31 (ddd, J = 8.9, 
4.5, 0.6 Hz, 1H), 7.25 (s, 1H), 6.87 (td, J = 9.1, 2.5 Hz, 1H), 3.71 (d, J = 6.9 Hz, 1H), 3.54 (p, J = 
7.2 Hz, 1H), 1.52 (d, J = 7.2 Hz, 3H). 19F NMR (282 MHz, Methanol-d4) δ –127.22 (td, J = 9.7, 
4.6 Hz). 13C NMR (101 MHz, Methanol-d4) δ 172.9, 157.5 (d, J = 232.2 Hz), 133.6, 126.5 (d, J 
= 9.8 Hz), 124.7, 114.00 (d, J = 4.9 Hz), 111.8 (d, J = 9.7 Hz), 109.4 (d, J = 26.6 Hz), 103.5 (d, J 
= 24.0 Hz), 60.0, 33.5, 18.1. MS (FAB) for [M+H]+ C12H14FN2O2 requires 237.1039, observed 
237.1046. 
 
(2S,3R)-2-amino-3-(1H-indazol-1-yl)butanoic acid. A 20 mL vial was charged with indazole 
(22.4 mg) and L-Thr  (74.2 mg). The substrates were suspended in 0.14 mL of aq. potassium 
phosphate (0.2 M, pH 8.0) with 100 µL DMSO (5% of final volume), then aq. PLP was added 
from a 15 mM stock solution to achieve a final concentration of 100 µM. Lastly, 1667 µL of 160 
µM PfTrpB2B9 was added as a heat-treated lysate for a final reaction volume of 2.0 mL with 0.13 
mol % catalyst loading with respect to indazole. The reaction was allowed to proceed in a water 
bath at 75 °C. After 1 h, 77.2 mg additional Thr was added. After 2 h, 86.3 mg of Thr were 
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added for a final amount of 238.2 mg Thr (10 eq). The reaction was allowed to proceed 
overnight at 75 °C. Approximately 30 % of indazole was converted to product, as indicated by 
the UV absorbance at 280 nm from LC-MS analysis of the reaction mixture. The product was 
purified using automated flash chromatography using a C18-silica column with a gradient from 0 
to 100% acetonitrile. The fractions containing product, as indicated by LC-MS, were pooled and 
concentrated by rotary evaporation. The white solid was dissolved in 2 mL H2O, frozen on dry 
ice, and lyophilized overnight. This procedure afforded 14.0 mg of product for an isolated yield 
of 33%. Marfey’s analysis of the product indicated the reaction proceeded with > 99 % ee. 
1H NMR (300 MHz, Methanol-d4) δ 8.07 (d, J = 0.8 Hz, 1H), 7.73 (dt, J = 8.1, 1.0 Hz, 1H), 7.62 
(dt, J = 8.6, 0.9 Hz, 1H), 7.40 (ddd, J = 8.5, 6.9, 1.1 Hz, 1H), 7.15 (ddd, J = 8.0, 6.9, 0.8 Hz, 1H), 
5.43 (qd, J = 7.0, 4.7 Hz, 1H), 4.06 (d, J = 4.7 Hz, 1H), 1.62 (d, J = 7.1 Hz, 4H). 13C NMR (101 
MHz, Methanol-d4) δ 172.6, 141.6, 135.8, 128.2, 125.3, 122.5, 122.3, 110.9, 61.0, 54.9, 19.2. 
MS (FAB) (m/z) for [M+H]+ C11H14N3O2 requires 220.1086, observed 220.1114. 
 
(2S,3S)-2-amino-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)butanoic acid. A 6 mL vial was charged 
with 7-azaindole (23.6 mg) and L-Thr (238.2 mg). The substrates were suspended in 0.144 mL 
aq. potassium phosphate (0.2 M, pH 8.0) with 100 µL DMSO (5% of the final volume), then aq. 
PLP was added from a 15 mM stock solution to achieve a final concentration of 660 µM. Lastly, 
1667 µL of 160 µM PfTrpB2B9 was added as a heat-treated lysate for a final reaction volume of 
2.0 mL with 0.13 mol % catalyst loading with respect to 7-azaindole. The mixture was then 
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sparged with Ar(g) to remove O2. The reaction was allowed to proceed overnight at 75 °C in a 
water bath. The product was purified using the same protocol as described for 6-methyl-β-
methyltryptophan. In the late-eluting fraction from the column, a second peak with m/z = 220 
was observed, suggestive of N-alkylation. This fraction was a mixture of products and was kept 
separate for characterization. 1H-NMR later indicated a product consistent with N-alkylation, 
however the compound was not characterized further. The fractions containing the anticipated C-
alkylation product were pooled and concentrated by rotary evaporation. The white solid was 
dissolved in 2 mL H2O, frozen on dry ice, and lyophilized overnight. This procedure afforded 7.6 
mg of product for an isolated yield of 17%, from which the N-alkylated compound was 
incompletely removed. Marfey’s analysis of the product indicated the reaction proceeded with > 
99 % ee. 
1H NMR (300 MHz, Methanol-d4) δ 8.19 (dd, J = 8.0, 1.5 Hz, 1H), 8.15 (dd, J = 4.8, 1.5 Hz, 
1H), 7.32 (s, 1H), 7.09 (dd, J = 7.9, 4.9 Hz, 1H), 3.74 (d, J = 6.2 Hz, 1H), 3.66 (p, J = 7.0 Hz, 
1H), 1.55 (d, J = 7.2 Hz, 3H). 13C NMR (101 MHz, Methanol-d4) δ 174.5, 149.9, 143.7, 130.2, 
125.6, 121.3, 116.7, 114.7, 61.6, 35.1, 19.5. MS (FAB) (m/z) for [M+H]+ C11H14N3O2 requires 
220.1086, observed 220.1088. 
 
(2R,3R)-2-amino-3-(phenylthio)butanoic acid. A 20 mL vial was charged with 12.8 µL of 
thiophenol (9.77 M, > 99 % pure),  followed by L-Thr (148.9 mg), and 1,4-dithiothreitol (96.4 
mg). The reactants were suspended in 5.808 mL of Ar(g)-sparged aq. potassium phosphate (0.2 
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M, pH 8.0) with 312.5 µL DMSO (5% of final volume), then aq. PLP was added from a 15 mM 
stock solution to achieve a final concentration of 50 µM. Lastly, 93.1 µL of 671 µM of 
PfTrpB2B9 prepared as a heat-treated lysate was added for a final reaction volume of 6.25 mL 
with 0.05 mol % catalyst loading with respect to thiophenol. To reduce exposure to oxygen, the 
reaction was transferred into a Coy anaerobic chamber. The reaction was allowed to proceed for 
1 week at room temperature until all of the thiophenol was either converted to product or 
oxidized. The reaction mixture was purified using the same protocol as described for 6-methyl-β-
methyltryptophan. A prominent peak was observed close to the product during purification that 
we attribute to the oxidized form of DTT. The fractions believed to contain the S-alkylation 
product, as indicated by LC-MS, were pooled and concentrated in a rotary evaporator. The white 
solid was dissolved in 2 mL H2O, frozen on dry ice, and lyophilized overnight. This procedure 
afforded 8.4 mg of product that was determined to be in a 2:1 mixture with oxidized DTT that 
was carried through during the purification. Marfey’s analysis of the product indicated the 
reaction proceeded with > 99 % ee. A high-resolution mass was obtained to confirm the 
production of (2R,3R)-2-amino-3-(phenylthio)butanoic acid, which was converted to its Boc-
derivative for further purification and characterization.  
MS (TOF) (MS ES+) for [M+H]+ C10H14NO2S requires 212.0745, observed 212.0734. 
 
(2R,3R)-2-((tert-butoxycarbonyl)amino)-3-(phenylthio)butanoic acid. A 20 mL vial was 
charged with 25.6 µL of thiophenol (9.77 M, > 99 % pure), followed by L-Thr (297.8 mg), and 
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1,4-dithiothreitol (19.3 mg). The reactants were suspended in 9.037 mL of aq. potassium 
phosphate (0.2 M, pH 8.0) with 100 µL DMSO (5% of final volume), then aq. PLP was added 
from a 15 mM stock solution to achieve a final concentration of 83 µM. Lastly, 125 µL of 650 
µM of purified PfTrpB2B9 was added for a final reaction volume of 10.0 mL with 0.03 mol % 
catalyst loading with respect to thiophenol. The mixture was then sparged with Ar(g) to remove 
O2. The reaction was allowed to proceed overnight at 37 °C. (Reactivity was also observed at 
higher temperature, however for isolation it was beneficial to conduct the reaction at lower 
temperature to increase the time window between consumption of starting material and enzyme-
catalyzed β-elimination of the product.)  
Of this crude reaction mixture, 5 mL were subjected to Boc-derivatization as follows: Boc2O 
(21.8 mg) was added along with 1 mL 1,4-dioxane. The mixture was allowed to sir for 5 h, after 
which there was an apparent 26% conversion by LC-MS. Additional Boc2O (110 mg) was added 
in 40, 50, and 20 mg increments over the course of 4 days while the derivatization proceeded to a 
final apparent conversion of 71 % by LC-MS. The product was purified by automated C18-silica 
column chromatography and the fractions containing the anticipated Boc-protected product were 
pooled and concentrated by rotary evaporation. The resulting white solid was dissolved in 1 mL 
H2O, frozen on dry ice, and lyophilized overnight. This procedure afforded 5.0 mg of product for 
an isolated yield of 14% over two steps.  
1H NMR (400 MHz, Methanol-d4) δ 7.50–7.43 (m, 2H), 7.32–7.18 (m, 3H), 4.17 (d, J = 4.9 Hz, 
1H), 3.69 (dt, J = 10.8, 5.6 Hz, 1H), 1.45 (s, 9H), 1.30 (d, J = 6.9 Hz, 3H). 13C NMR (101 MHz, 
Methanol-d4) δ 177.1, 157.7, 136.7, 133.4, 129.8, 127.9, 80.2, 61.9, 40.4, 28.7, 20.3. 
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NMR Spectra 
(2S,3S)-2-amino-3-(1H-indol-3-yl)butanoic acid 
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(2S,3S)-2-amino-3-(2-methyl-1H-indol-3-yl)butanoic acid 
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(2S,3S)-2-amino-3-(6-methyl-1H-indol-3-yl)butanoic acid. 
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(2S,3S)-2-amino-3-(4-fluoro-1H-indol-3-yl)butanoic acid 
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(2S,3S)-2-amino-3-(5-fluoro-1H-indol-3-yl)butanoic acid 
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(2S,3R)-2-amino-3-(1H-indazol-1-yl)butanoic acid 
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(2S,3S)-2-amino-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)butanoic acid 
 
 
 
 
H2O 
MeOH 
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Putative: (2S,3R)-2-amino-3-(1H-pyrrolo[2,3-b]pyridin-1-yl)butanoic acid. 
Peak at 5.2 ppm indicative of N-alkylation1.  
 
1H NMR (400 MHz, Methanol-d4) δ 8.23 (dd, J = 4.8, 1.5 Hz, 1H), 7.99 (dd, J = 7.9, 1.6 Hz, 
1H), 7.38 (d, J = 3.5 Hz, 1H), 6.48 (d, J = 3.5 Hz, 1H), 5.20 (qd, J = 7.2, 5.3 Hz, 1H), 4.05 (d, J 
= 5.4 Hz, 1H), 1.66 (d, J = 7.3 Hz, 3H). 
N-alkylated product is in a 2:1 ratio with the C-alkylated product.  
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(2R,3R)-2-amino-3-(phenylthio)butanoic acid in a 2:1 ratio with 1,2-dithiane-4,5-diol 
 
(2R,3R)-2-amino-3-(phenylthio)butanoic acid 
1H NMR (400 MHz, Methanol-d4) δ 7.55 – 7.48 (m, 2H), 7.36 – 7.26 (m, 3H), 3.52 (dt, J = 11.7, 
5.9 Hz, 1H), 3.37 (d, J = 6.7 Hz, 1H), 1.37 (d, J = 7.0 Hz, 3H). 
 
1,2-dithiane-4,5-diol 
1H NMR (400 MHz, Methanol-d4) δ 3.52 (m, 1H), 3.03 (d, J = 13.0 Hz, 1H), 2.87 (dd, J = 13.3, 
9.8 Hz, 1H) 
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(2R,3R)-2-amino-3-(phenylthio)butanoic acid in a 2:1 ratio with 1,2-dithiane-4,5-diol 
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(2R,3R)-2-((tert-butoxycarbonyl)amino)-3-(phenylthio)butanoic acid 
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